Surgery Partners Announces Q1 Earnings

Summary

Surgery Partners reported first-quarter adjusted earnings per share of $0.04, falling short of the Ibes estimate of $0.05. Pre-tax profit was -$300,000 compared to the Ibes estimate of $36.1 million. Revenue stood at $776 million, slightly below the expected $777.1 million, and operating income was $61.9 million, also below the estimate of $76.6 million. Adjusted EBITDA margin was 13.4% with adjusted EBITDA of $103.9 million, meeting the Ibes expectation of $103.8 million. Reuters

Impact Analysis

1. Business Overview Analysis

• business_model: Surgery Partners operates a healthcare services model focused on surgical facilities, including outpatient centers and specialty hospitals. The revenue streams primarily include surgical procedures, healthcare facility management, and related services.StockTitan
• market_position: As one of the largest surgical services enterprises in the US, Surgery Partners holds a competitive position. However, recent earnings suggest challenges in maintaining growth amidst rising operational costs.StockTitan
• recent_events_impact: The reaffirmation of 2025 fiscal guidance despite disappointing first-quarter results suggests management’s confidence in strategic initiatives to improve performance.rttnews

2. Financial Statement Analysis

• key_metrics:
• Income Statement: Revenue slightly missed expectations. Operating income decreased from the previous year. Net income shows a significant loss compared to a smaller loss last year.Reuters+ 2
• Balance Sheet: Rising operational expenses indicate pressure on margins. Further analysis of asset quality and liabilities would be needed for a full assessment.Earnings Watch
• Cash Flow: Operating cash flow decreased significantly from the previous year, indicating potential liquidity concerns.Earnings Watch
• strengths:
• Stable adjusted EBITDA performance against expectations.Reuters
• weaknesses:
• Revenue and operating income underperformance, suggesting potential inefficiencies or slowdown in demand.Reuters